Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cns Pharmaceuticals Inc
(NQ:
CNSP
)
0.2349
+0.0100 (+4.45%)
Streaming Delayed Price
Updated: 9:57 AM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cns Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation in Upcoming Maxim Group Virtual Healthcare Conference
June 15, 2023
Via
Investor Brand Network
CNS Pharmaceuticals (NASDAQ:CNSP) to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest
June 14, 2023
Via
ACCESSWIRE
Researchers Explain How Brain Cancers Hijack Neural Circuits
June 13, 2023
Via
Investor Brand Network
Scientists Create Open-Source Platform to Analyze Brain Tumors in Kids
June 07, 2023
Via
Investor Brand Network
Study Shows Brain Cancer Among Top Cancer Types in US
June 01, 2023
Via
Investor Brand Network
Researchers Find New Way to Detect Brain Tumors Using Urine Tests
May 16, 2023
Via
Investor Brand Network
CNS Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 15, 2023
Via
ACCESSWIRE
New Gel Cures Brain Tumors in Mice
May 02, 2023
Via
Investor Brand Network
Biotechs Zeroing In on Developing Breakthrough Therapeutics for Metastatic Breast Cancer
June 05, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(NASDAQ:GILD),(NASDAQ:RAIN),(NASDAQ:CNSP),(NYSE:BMY) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
COVID-19
Proton Beam Therapy Could Boost Quality of Life for Cancer Patients
May 25, 2023
Via
Investor Brand Network
Topics
Death
Exposures
Death
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Achieves 50%+ Enrollment in Potentially Pivotal Berubicin Study
May 25, 2023
Via
Investor Brand Network
CNS Pharmaceuticals to Present at the Virtual Investor Spotlight Event - Rapidly Advancing GBM Pivotal Study
April 27, 2023
Via
ACCESSWIRE
CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Near the Top of Equities by Percentage Gain on 4/20
April 20, 2023
Via
Investor Brand Network
CNS Pharmaceuticals (NASDAQ:CNSP) Achieves Over 50% Completion of Enrollment in Potentially Pivotal Study with Berubicin for the Treatment of Glioblastoma Multiforme (GBM)
May 25, 2023
Via
ACCESSWIRE
Notable Advancements Made in Research, Treatment of Brain Cancer
May 19, 2023
Via
Investor Brand Network
Topics
Death
Exposures
Death
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Q1 2023 Results, Corporate Update
May 15, 2023
Via
Investor Brand Network
Study Finds Possible Pathway to Prevent Brain Cancer Metastasis
May 11, 2023
Via
Investor Brand Network
Researchers Use Genome Sequencing to Determine Genes That Trigger Familial Glioma
May 08, 2023
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Board Appointment of Pharma and Biotech Industry Veteran Dr. Bettina M. Cockroft
May 08, 2023
Via
Investor Brand Network
Bettina M. Cockroft, M.D., M.B.A., Pharmaceutical and Biotech Industry Veteran, Joins CNS Pharmaceuticals Board of Directors
May 08, 2023
Via
ACCESSWIRE
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Retains Analytics Firm, Investigates Possible Naked Short Selling
May 03, 2023
Via
Investor Brand Network
Topics
Law Enforcement
Exposures
Legal
CNS Pharmaceuticals Investigating Potential Naked Short Selling; Retains Shareholder Intelligence Services, LLC
May 03, 2023
Via
ACCESSWIRE
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Participate, Present at Upcoming Virtual Investor Spotlight Event
April 27, 2023
Via
Investor Brand Network
Study Finds Traditional Chinese Medicine May Create New Way to Treat Brain Cancer
April 26, 2023
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advancing Potentially Pivotal Berubicin Trial
April 21, 2023
Via
Investor Brand Network
Mechanical Nanosurgery Could Revolutionize Brain Cancer Treatment
April 20, 2023
Via
Investor Brand Network
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Global Trial Targets Unmet Medical Need in Arresting GBM Brain Cancer
April 13, 2023
Via
Investor Brand Network
Study Explores Effects of MRI Scans During Cancer Treatment
April 12, 2023
Via
Investor Brand Network
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Enrolls First Patient in Switzerland in Its Potentially Pivotal Global GBM Trial, Reports No Exposure to SVB Issues
April 11, 2023
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enrolls Over 100 Patients in Potentially Pivotal Berubicin Study
April 10, 2023
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.